Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isovue vs Visipaque in Diabetic Patients with Renal Impairment
NCT00289614Phase 4Completed
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of iopamidol (2 arms), sponsored by Bracco Diagnostics Inc. Primary endpoint: Increase in serum creatinine. Started Jan 2006; status: completed.
02
Drugs
iopamidol
Beyond the preview
Go deeper on NCT00289614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289614.